Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2025)

Maravai Lifesciences Holdings has reported Free Cash Flow over the past 6 years, most recently at -$15.4 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$15.4 million for Q4 2025, up 24.82% from a year ago — trailing twelve months through Dec 2025 was -$61.2 million (down 175.95% YoY), and the annual figure for FY2025 was -$61.2 million, down 175.95%.
  • Free Cash Flow for Q4 2025 was -$15.4 million at Maravai Lifesciences Holdings, up from -$24.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for MRVI hit a ceiling of $161.6 million in Q2 2022 and a floor of -$54.1 million in Q4 2023.
  • Median Free Cash Flow over the past 5 years was $18.8 million (2023), compared with a mean of $43.9 million.
  • Biggest five-year swings in Free Cash Flow: soared 2717.84% in 2021 and later plummeted 638.24% in 2025.
  • Maravai Lifesciences Holdings' Free Cash Flow stood at $57.5 million in 2021, then soared by 88.84% to $108.5 million in 2022, then plummeted by 149.82% to -$54.1 million in 2023, then surged by 62.1% to -$20.5 million in 2024, then rose by 24.82% to -$15.4 million in 2025.
  • The last three reported values for Free Cash Flow were -$15.4 million (Q4 2025), -$24.5 million (Q3 2025), and -$6.8 million (Q2 2025) per Business Quant data.